China Epoprostenol Market Report & Forecast 2021-2027

Publisher Name :
Date: 28-Dec-2021
No. of pages: 94
Inquire Before Buying

China Epoprostenol Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (MT)

China Epoprostenol Market Segment Percentages, By Type, 2020 (%)

- Oral Epoprostenol

- Injection Epoprostenol

China Epoprostenol Market, By Sale Channel, 2016-2021, 2022-2027 ($ Millions) & (MT)

China Epoprostenol Market Segment Percentages, By Sale Channel, 2020 (%)

- Hospital Pharmacy

- Retail Pharmacy

- Online Pharmacy

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Epoprostenol revenues in China market, 2016-2021 (Estimated), ($ millions)

Key companies Epoprostenol revenues share in China market, 2020 (%)

Key companies Epoprostenol sales in China market, 2016-2021 (Estimated), (MT)

Key companies Epoprostenol sales share in China market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

- Actelion

- Glaxosmithkline Inc

- Sandoz Canada Incorporated

- Teva Parenteral

- Bayer AG

- SteadyMed

- Reata Pharmaceuticals

- Arena Pharmaceuticals

- Merck

China Epoprostenol Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Epoprostenol Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Sale Channel
1.3 China Epoprostenol Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Epoprostenol Overall Market Size
2.1 China Epoprostenol Market Size: 2021 VS 2027
2.2 China Epoprostenol Revenue, Prospects & Forecasts: 2016-2027
2.3 China Epoprostenol Sales: 2016-2027
3 Company Landscape
3.1 Top Epoprostenol Players in China Market
3.2 Top China Epoprostenol Companies Ranked by Revenue
3.3 China Epoprostenol Revenue by Companies
3.4 China Epoprostenol Sales by Companies
3.5 China Epoprostenol Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Epoprostenol Companies in China Market, by Revenue in 2020
3.7 Manufacturers Epoprostenol Product Type
3.8 Tier 1, Tier 2 and Tier 3 Epoprostenol Players in China Market
3.8.1 List of Tier 1 Epoprostenol Companies in China
3.8.2 List of Tier 2 and Tier 3 Epoprostenol Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China Epoprostenol Market Size Markets, 2021 & 2027
4.1.2 Oral Epoprostenol
4.1.3 Injection Epoprostenol
4.2 By Type - China Epoprostenol Revenue & Forecasts
4.2.1 By Type - China Epoprostenol Revenue, 2016-2021
4.2.2 By Type - China Epoprostenol Revenue, 2022-2027
4.2.3 By Type - China Epoprostenol Revenue Market Share, 2016-2027
4.3 By Type - China Epoprostenol Sales & Forecasts
4.3.1 By Type - China Epoprostenol Sales, 2016-2021
4.3.2 By Type - China Epoprostenol Sales, 2022-2027
4.3.3 By Type - China Epoprostenol Sales Market Share, 2016-2027
4.4 By Type - China Epoprostenol Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Sale Channel
5.1 Overview
5.1.1 By Sale Channel - China Epoprostenol Market Size, 2021 & 2027
5.1.2 Hospital Pharmacy
5.1.3 Retail Pharmacy
5.1.4 Online Pharmacy
5.2 By Sale Channel - China Epoprostenol Revenue & Forecasts
5.2.1 By Sale Channel - China Epoprostenol Revenue, 2016-2021
5.2.2 By Sale Channel - China Epoprostenol Revenue, 2022-2027
5.2.3 By Sale Channel - China Epoprostenol Revenue Market Share, 2016-2027
5.3 By Sale Channel - China Epoprostenol Sales & Forecasts
5.3.1 By Sale Channel - China Epoprostenol Sales, 2016-2021
5.3.2 By Sale Channel - China Epoprostenol Sales, 2022-2027
5.3.3 By Sale Channel - China Epoprostenol Sales Market Share, 2016-2027
5.4 By Sale Channel - China Epoprostenol Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Actelion
6.1.1 Actelion Corporation Information
6.1.2 Actelion Overview
6.1.3 Actelion Epoprostenol Sales and Revenue in China Market (2016-2021)
6.1.4 Actelion Epoprostenol Product Description
6.1.5 Actelion Recent Developments
6.2 Glaxosmithkline Inc
6.2.1 Glaxosmithkline Inc Corporation Information
6.2.2 Glaxosmithkline Inc Overview
6.2.3 Glaxosmithkline Inc Epoprostenol Sales and Revenue in China Market (2016-2021)
6.2.4 Glaxosmithkline Inc Epoprostenol Product Description
6.2.5 Glaxosmithkline Inc Recent Developments
6.3 Sandoz Canada Incorporated
6.3.1 Sandoz Canada Incorporated Corporation Information
6.3.2 Sandoz Canada Incorporated Overview
6.3.3 Sandoz Canada Incorporated Epoprostenol Sales and Revenue in China Market (2016-2021)
6.3.4 Sandoz Canada Incorporated Epoprostenol Product Description
6.3.5 Sandoz Canada Incorporated Recent Developments
6.4 Teva Parenteral
6.4.1 Teva Parenteral Corporation Information
6.4.2 Teva Parenteral Overview
6.4.3 Teva Parenteral Epoprostenol Sales and Revenue in China Market (2016-2021)
6.4.4 Teva Parenteral Epoprostenol Product Description
6.4.5 Teva Parenteral Recent Developments
6.5 Bayer AG
6.5.1 Bayer AG Corporation Information
6.5.2 Bayer AG Overview
6.5.3 Bayer AG Epoprostenol Sales and Revenue in China Market (2016-2021)
6.5.4 Bayer AG Epoprostenol Product Description
6.5.5 Bayer AG Recent Developments
6.6 SteadyMed
6.6.1 SteadyMed Corporation Information
6.6.2 SteadyMed Overview
6.6.3 SteadyMed Epoprostenol Sales and Revenue in China Market (2016-2021)
6.6.4 SteadyMed Epoprostenol Product Description
6.6.5 SteadyMed Recent Developments
6.7 Reata Pharmaceuticals
6.7.1 Reata Pharmaceuticals Corporation Information
6.7.2 Reata Pharmaceuticals Overview
6.7.3 Reata Pharmaceuticals Epoprostenol Sales and Revenue in China Market (2016-2021)
6.7.4 Reata Pharmaceuticals Epoprostenol Product Description
6.7.5 Reata Pharmaceuticals Recent Developments
6.8 Arena Pharmaceuticals
6.8.1 Arena Pharmaceuticals Corporation Information
6.8.2 Arena Pharmaceuticals Overview
6.8.3 Arena Pharmaceuticals Epoprostenol Sales and Revenue in China Market (2016-2021)
6.8.4 Arena Pharmaceuticals Epoprostenol Product Description
6.8.5 Arena Pharmaceuticals Recent Developments
6.9 Merck
6.9.1 Merck Corporation Information
6.9.2 Merck Overview
6.9.3 Merck Epoprostenol Sales and Revenue in China Market (2016-2021)
6.9.4 Merck Epoprostenol Product Description
6.9.5 Merck Recent Developments
7 China Epoprostenol Production Capacity, Analysis
7.1 China Epoprostenol Production Capacity, 2016-2027
7.2 Epoprostenol Production Capacity of Key Manufacturers in China Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Epoprostenol Supply Chain Analysis
9.1 Epoprostenol Industry Value Chain
9.2 Epoprostenol Upstream Market
9.3 Epoprostenol Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Epoprostenol Distributors and Sales Agents in China Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of Tables
Table 1. Key Players of Epoprostenol in China Market
Table 2. Top Epoprostenol Players in China Market, Ranking by Revenue (2019)
Table 3. China Epoprostenol Revenue by Companies, (US$, Mn), 2016-2021
Table 4. China Epoprostenol Revenue Share by Companies, 2016-2021
Table 5. China Epoprostenol Sales by Companies, (MT), 2016-2021
Table 6. China Epoprostenol Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Epoprostenol Price (2016-2021) & (USD/MT)
Table 8. Manufacturers Epoprostenol Product Type
Table 9. List of Tier 1 Epoprostenol Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Epoprostenol Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Oral Epoprostenol
Table 12. Major Manufacturers of Injection Epoprostenol
Table 13. By Type - China Epoprostenol Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - China Epoprostenol Revenue (US$, Mn), 2016-2021
Table 15. By Type - China Epoprostenol Revenue (US$, Mn), 2022-2027
Table 16. By Type - China Epoprostenol Sales (MT), 2016-2021
Table 17. By Type - China Epoprostenol Sales (MT), 2022-2027
Table 18. By Sale Channel - China Epoprostenol Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Sale Channel - China Epoprostenol Revenue (US$, Mn), 2016-2021
Table 20. By Sale Channel - China Epoprostenol Revenue (US$, Mn), 2022-2027
Table 21. By Sale Channel - China Epoprostenol Sales (MT), 2016-2021
Table 22. By Sale Channel - China Epoprostenol Sales (MT), 2022-2027
Table 23. Actelion Corporation Information
Table 24. Actelion Description and Major Businesses
Table 25. Actelion Epoprostenol Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 26. Actelion Epoprostenol Product
Table 27. Actelion Recent Developments
Table 28. Glaxosmithkline Inc Corporation Information
Table 29. Glaxosmithkline Inc Description and Major Businesses
Table 30. Glaxosmithkline Inc Epoprostenol Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 31. Glaxosmithkline Inc Epoprostenol Product
Table 32. Glaxosmithkline Inc Recent Developments
Table 33. Sandoz Canada Incorporated Corporation Information
Table 34. Sandoz Canada Incorporated Description and Major Businesses
Table 35. Sandoz Canada Incorporated Epoprostenol Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 36. Sandoz Canada Incorporated Epoprostenol Product
Table 37. Sandoz Canada Incorporated Recent Developments
Table 38. Teva Parenteral Corporation Information
Table 39. Teva Parenteral Description and Major Businesses
Table 40. Teva Parenteral Epoprostenol Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 41. Teva Parenteral Epoprostenol Product
Table 42. Teva Parenteral Recent Developments
Table 43. Bayer AG Corporation Information
Table 44. Bayer AG Description and Major Businesses
Table 45. Bayer AG Epoprostenol Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 46. Bayer AG Epoprostenol Product
Table 47. Bayer AG Recent Developments
Table 48. SteadyMed Corporation Information
Table 49. SteadyMed Description and Major Businesses
Table 50. SteadyMed Epoprostenol Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 51. SteadyMed Epoprostenol Product
Table 52. SteadyMed Recent Developments
Table 53. Reata Pharmaceuticals Corporation Information
Table 54. Reata Pharmaceuticals Description and Major Businesses
Table 55. Reata Pharmaceuticals Epoprostenol Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 56. Reata Pharmaceuticals Epoprostenol Product
Table 57. Reata Pharmaceuticals Recent Developments
Table 58. Arena Pharmaceuticals Corporation Information
Table 59. Arena Pharmaceuticals Description and Major Businesses
Table 60. Arena Pharmaceuticals Epoprostenol Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 61. Arena Pharmaceuticals Epoprostenol Product
Table 62. Arena Pharmaceuticals Recent Developments
Table 63. Merck Corporation Information
Table 64. Merck Description and Major Businesses
Table 65. Merck Epoprostenol Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 66. Merck Epoprostenol Product
Table 67. Merck Recent Developments
Table 68. Epoprostenol Production Capacity (MT) of Key Manufacturers in China Market, 2019-2021 (MT)
Table 69. China Epoprostenol Capacity Market Share of Key Manufacturers, 2019-2021
Table 70. Epoprostenol Market Opportunities & Trends in China Market
Table 71. Epoprostenol Market Drivers in China Market
Table 72. Epoprostenol Market Restraints in China Market
Table 73. Epoprostenol Raw Materials
Table 74. Epoprostenol Raw Materials Suppliers in China Market
Table 75. Typical Epoprostenol Downstream
Table 76. Epoprostenol Downstream Clients in China Market
Table 77. Epoprostenol Distributors and Sales Agents in China Market
List of Figures
Figure 1. Epoprostenol Product Picture
Figure 2. Epoprostenol Segment by Type
Figure 3. Epoprostenol Segment by Sale Channel
Figure 4. China Epoprostenol Market Overview: 2020
Figure 5. China Epoprostenol Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. China Epoprostenol Revenue, 2016-2027 (US$, Mn)
Figure 7. Epoprostenol Sales in China Market: 2016-2027 (MT)
Figure 8. The Top 3 and 5 Players Market Share by Epoprostenol Revenue in 2020
Figure 9. Oral Epoprostenol Product Picture
Figure 10. Injection Epoprostenol Product Picture
Figure 11. By Type - China Epoprostenol Sales Market Share, 2016-2027
Figure 12. By Type - China Epoprostenol Revenue Market Share, 2016-2027
Figure 13. By Type - China Epoprostenol Price (USD/MT), 2016-2027
Figure 14. Hospital Pharmacy
Figure 15. Retail Pharmacy
Figure 16. Online Pharmacy
Figure 17. By Sale Channel - China Epoprostenol Sales Market Share, 2016-2027
Figure 18. By Sale Channel - China Epoprostenol Revenue Market Share, 2016-2027
Figure 19. By Sale Channel - China Epoprostenol Price (USD/MT), 2016-2027
Figure 20. Actelion Epoprostenol Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 21. Glaxosmithkline Inc Epoprostenol Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. Sandoz Canada Incorporated Epoprostenol Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Teva Parenteral Epoprostenol Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Bayer AG Epoprostenol Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. SteadyMed Epoprostenol Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Reata Pharmaceuticals Epoprostenol Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. Arena Pharmaceuticals Epoprostenol Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. Merck Epoprostenol Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. China Epoprostenol Production Capacity (MT), 2016-2027
Figure 30. Epoprostenol Industry Value Chain
Figure 31. Marketing Channels
  • Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87
    The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......
  • Global Esomeprazole Magnesium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74
    The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......
  • Global Combination Therapy Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......
  • Global Axitinib Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68
    The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......
  • Global Lyme Disease Vaccine Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70
    The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......
  • Global Transdermal Absorption Patch Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......
  • Global Ketoprofen Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......
  • Global Methyl Salicylate Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82
    The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......
  • Global Diclofenac Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs